236 related articles for article (PubMed ID: 29041934)
21. Autoinflammation in addition to combined immunodeficiency: SLC29A3 gene defect.
Çağdaş D; Sürücü N; Tan Ç; Kayaoğlu B; Özgül RK; Akkaya-Ulum YZ; Aydınoğlu AT; Aytaç S; Gümrük F; Balci-Hayta B; Balci-Peynircioğlu B; Özen S; Gürsel M; Tezcan İ
Mol Immunol; 2020 May; 121():28-37. PubMed ID: 32151906
[TBL] [Abstract][Full Text] [Related]
22. Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.
Al-Haggar M; Salem N; Wahba Y; Ahmad N; Jonard L; Abdel-Hady D; El-Hawary A; El-Sharkawy A; Eid AR; El-Hawary A
Pediatr Diabetes; 2015 Jun; 16(4):305-16. PubMed ID: 24894595
[TBL] [Abstract][Full Text] [Related]
23. Atypical comorbidities in a child considered to have type 1 diabetes led to the diagnosis of SLC29A3 spectrum disorder.
Besci Ö; Patel KA; Yıldız G; Tüfekçi Ö; Acinikli KY; Erbaş İM; Abacı A; Böber E; Bayram MT; Yılmaz Ş; Demir K
Hormones (Athens); 2022 Sep; 21(3):501-506. PubMed ID: 35284993
[TBL] [Abstract][Full Text] [Related]
24. Glomerular involvement in children with H syndrome.
David O; Geylis M; Kristal E; Ling G; Schreiber R
Pediatr Nephrol; 2021 Mar; 36(3):721-724. PubMed ID: 33387019
[TBL] [Abstract][Full Text] [Related]
25. Functional outcome of a novel SLC29A3 mutation identified in a patient with H syndrome.
Huber-Ruano I; Errasti-Murugarren E; Godoy V; Vera Á; Andreu AL; Garcia-Arumi E; Martí R; Pastor-Anglada M
Biochem Biophys Res Commun; 2012 Nov; 428(4):532-7. PubMed ID: 23058913
[TBL] [Abstract][Full Text] [Related]
26. Renal Involvement in H Syndrome, A Rare Cause of Diabetes Mellitus: Case Report.
Polat R; Ustyol A; Altunbaş R; Ceylaner S
Endocr Metab Immune Disord Drug Targets; 2023; 23(5):727-731. PubMed ID: 36372920
[TBL] [Abstract][Full Text] [Related]
27. Cases with the H syndrome presenting with skin and bone findings.
Kose H; Baskaya MD; Kilic SS
Australas J Dermatol; 2024 Jun; 65(4):337-341. PubMed ID: 38421823
[TBL] [Abstract][Full Text] [Related]
28. Improvement of SLC29A3 spectrum disorder-related sensorineural hearing loss after initiation of IL-6 inhibitor.
Gunderman LM; Valika T; Carol H; Khojah A
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732371
[TBL] [Abstract][Full Text] [Related]
29. Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.
Ventura-Espejo L; Gracia-Darder I; Escribá-Bori S; Amador-González ER; Martín-Santiago A; Ramakers J
Pediatr Rheumatol Online J; 2021 Jun; 19(1):104. PubMed ID: 34193201
[TBL] [Abstract][Full Text] [Related]
30. Case report of H-syndrome with a review from a rheumatological perspective.
Yadav S; Canchi B
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732361
[TBL] [Abstract][Full Text] [Related]
31. Early-onset sensorineural hearing loss is a prominent feature of H syndrome.
Ramot Y; Sayama K; Sheffer R; Doviner V; Hiller N; Kaufmann-Yehezkely M; Zlotogorski A
Int J Pediatr Otorhinolaryngol; 2010 Jul; 74(7):825-7. PubMed ID: 20399510
[TBL] [Abstract][Full Text] [Related]
32. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil treatment of an H syndrome patient with a SLC29A3 mutation.
Behrangi E; Sadeghzadeh-Bazargan A; Khosravi S; Shemshadi M; Youssefian L; Vahidnezhad H; Goodarzi A; Uitto J
Dermatol Ther; 2020 Nov; 33(6):e14375. PubMed ID: 33029882
[TBL] [Abstract][Full Text] [Related]
34. Hyperglycemia with hypogonadism and growth hormone deficiency in a 17-year-old male with H syndrome: the first case report from Syria.
Hamsho S; Alaswad M; Sleiay M; Alhusseini A
BMC Endocr Disord; 2023 Dec; 23(1):274. PubMed ID: 38093297
[TBL] [Abstract][Full Text] [Related]
35. A novel 3' untranslated region mutation in the SLC29A3 gene associated with pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus syndrome.
Riachi M; Bas F; Darendeliler F; Hussain K
Pediatr Diabetes; 2019 Jun; 20(4):474-481. PubMed ID: 30821020
[TBL] [Abstract][Full Text] [Related]
36. H syndrome with a novel homozygous SLC29A3 mutation in two sisters.
Demir D; Aktaş Karabay E; Sözeri B; Gürsoy F; Akgün Doğan Ö; Topaktaş E; Zindancı İ
Pediatr Dermatol; 2020 Nov; 37(6):1135-1138. PubMed ID: 32776596
[TBL] [Abstract][Full Text] [Related]
37. [H syndrome: First reported paediatric case in Latin America].
Abarca Barriga HH; Trubnykova M; Polar Córdoba V; Ramos Diaz KJ; Aviles Alfaro N
Rev Chil Pediatr; 2016; 87(6):494-499. PubMed ID: 27143505
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel homozygous frameshift mutation in SLC29A3 gene in a case with H syndrome from Iran.
Bagherian R; Yousefipour F; Mousavi HS; Saffari F; HajiShafieha E; Mohammadi SN; Mousakhani H; Fathi SM; Mehrtash A; Verki FM; Lee D; Heidari A
Curr Res Transl Med; 2019 May; 67(2):72-75. PubMed ID: 30723056
[TBL] [Abstract][Full Text] [Related]
39. Rheumatological complaints in H syndrome: from inflammatory profiling to target treatment in a case study.
Tesser A; Valencic E; Boz V; Tornese G; Pastore S; Zanatta M; Tommasini A
Pediatr Rheumatol Online J; 2024 Jan; 22(1):21. PubMed ID: 38263041
[TBL] [Abstract][Full Text] [Related]
40. Compound heterozygous SLC29A3 mutation causes H syndrome in a Moroccan patient: A case report.
Bakhchane A; Kindil Z; Charoute H; Benchikhi K; Khadir K; Nadifi S; Baline K; Roky R; Barakat A
Curr Res Transl Med; 2016; 64(2):65-8. PubMed ID: 27316388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
